Peripheral artery disease

Cilostazol: what it's used for and what effects it has

Cilostazol helps you walk farther in intermittent claudication. What it's used for, its effects, when it's contraindicated, and alternatives.

By Dr. Vicente Mosquera ·Jun 30, 2026 · 7 min read

Key points

  • Cilostazol is a medication that helps you walk farther without pain in intermittent claudication.
  • It acts as an antiplatelet agent and artery dilator, making it harder for platelets to form clots.
  • Not everyone can take it: it is contraindicated in people with heart failure.
  • It does not replace quitting smoking or walking every day; it is a support within the overall treatment.

Informative and educational content, reviewed by Dr. Vicente Mosquera. It does not replace the consultation, diagnosis or treatment of a healthcare professional.

If you've been diagnosed with poor circulation in your legs and pain when walking, your doctor may have mentioned cilostazol. It is one of the most widely used medications for intermittent claudication. Here, in plain language, is what it's used for, what effects it can have, and when it's not advisable.

What it is and what it's used for

Cilostazol is a medication used to improve the symptoms of intermittent claudication: the leg pain that appears when walking and forces you to stop. Its goal is to help you walk farther before the pain sets in, and with that, gain quality of life.

It is not a medication for one-off pain, nor a painkiller. It is taken continuously and its effect is assessed over several weeks. It is prescribed by the doctor when symptoms limit daily life and there are no contraindications.

How it works

Cilostazol has a dual effect. On one hand, it dilates the arteries, which improves blood flow to the muscle. On the other, it makes it harder for platelets to aggregate, that is, to form small clots. This combination helps the leg work better with the blood supply available.

Its limitations should be clear: it does not remove cholesterol plaques from the arteries or cure the underlying disease. It improves the symptom, but atherosclerosis is slowed down through lifestyle habits and, when needed, treatment on the artery itself.

Dr. Vicente Mosquera Rey

Cilostazol is a useful tool, but it's a support, not the solution. The patient who quits smoking and walks every day improves far more than the one who relies on the pill alone.

— Dr. Vicente Mosquera Rey, specialist in Angiology and Vascular and Endovascular Surgery

Common side effects

Like any medication, cilostazol can cause unwanted effects. The most common are mild and tend to appear at the start:

  • Headache, the most frequent effect.
  • Diarrhea or digestive discomfort.
  • Palpitations or a sensation of a racing heartbeat.
  • Dizziness.

If these effects are intense or don't ease, tell your doctor: sometimes the dose is adjusted or the medication is stopped. Don't stop or change the dose on your own.

When it should not be taken

There is one important contraindication: cilostazol must not be taken if you have heart failure. That's why the doctor reviews your cardiac history before prescribing it. It is also considered carefully if you take anticoagulants or antiplatelet agents, because of the risk of bleeding.

This is why cilostazol should never be bought or taken on your own initiative: the decision depends on your full cardiovascular situation, which must be evaluated by a professional.

Alternatives and baseline treatment

Cilostazol is only one piece of the puzzle. The treatment that truly changes the prognosis is:

MeasureWhat it's for
Quitting smokingThe most effective measure to slow down arterial disease.
Prescribed exerciseWalking daily, 45 minutes to 1 hour.
Controlling blood pressure, blood sugar, and cholesterolProtects the arteries of the legs, heart, and brain.
RevascularizationIn advanced cases, restores blood flow.

If cilostazol is not tolerated or is contraindicated, the specialist considers other pharmacological options and, above all, treatment of the artery itself when appropriate. You'll find more detail on the peripheral arterial disease treatment page.

In summary

Cilostazol helps you walk farther and with less pain, but it does not cure the disease or replace lifestyle changes. It should only be prescribed by a doctor who knows your heart and the rest of your medication. If you have claudication and doubts about your treatment, the best step is a vascular assessment that brings all the pieces together.

Frequently asked questions

How long does cilostazol take to work?

Improvement in walking distance is usually noticed gradually over several weeks, not overnight. The specialist assesses whether it is working before keeping it as a long-term treatment.

Does cilostazol dissolve plaque in the arteries?

No. It does not remove atherosclerosis or "clean" the arteries. It helps the muscle work better with the blood supply it receives and improves symptoms, but the underlying cause is managed with lifestyle habits and, if needed, revascularization.

Can cilostazol be taken with other medications?

It interacts with several drugs, including some anticoagulants and antiplatelet agents. This is why it should only be prescribed and adjusted by a doctor who knows the rest of your treatment. Never combine it on your own.

What if I have heart problems?

Cilostazol is contraindicated if you have heart failure. In that case the specialist will look for other options. Always report your cardiac history before starting any treatment.

More about the treatment: Peripheral artery disease.

How can we help you?

Get in touch and we will review your case

In accordance with data protection regulations, we provide the following information about the processing of your data: Data controller: Vicente Mosquera Rey. Purpose: to handle your request and contact you to provide the information requested. Your rights: access, rectification, portability, erasure, restriction and objection, as well as other rights detailed in the additional information. + info: you can find more detailed information in our privacy policy.